"Cancer Treatment Centers of America® (CTCA), Phoenix, is a comprehensive cancer care and research center located west of downtown Phoenix in Goodyear, Arizona. CTCA® is dedicated to tailoring a combination of cancer treatments to the needs of each individual patient. Comprehensive cancer services, from advanced genomic testing to clinical trials and evidence-informed supportive therapies, are delivered by a team of experts, all under one roof. Our oncologists offer a level of expertise that comes from working with cancer patients every day to deliver personalized medicine using today's scientific advances. We treat patients with all types and stages of cancer, at any point in their journey. Cancer treatment is our specialty."

During the past decade, CTCA at Western Regional Medical Center conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 8 clinical trials were completed, i.e. on average, 15.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 7 clinical trials were completed. i.e. 38.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CTCA at Western Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "Western Regional Medical Center" with 5 trials sponsored, "NRG Oncology" with 4 trials sponsored, "SWOG Cancer Research Network" with 4 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CTCA at Western Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "ARMO BioSciences" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "CTCA at Western Regional Medical Center" are "Breast Cancer" (5 trials), "Pancreatic Cancer" (4 trials), "Advanced Cancer" (3 trials), "Primary Peritoneal High Grade Serous Adenocarcinoma" (3 trials) and "Recurrent Melanoma" (3 trials). Many other conditions were trialed in "CTCA at Western Regional Medical Center" in a lesser frequency.

Most popular intervention types in "CTCA at Western Regional Medical Center" are "Drug" (47 trials), "Biological" (25 trials), "Other" (20 trials), "Procedure" (18 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (11 trials), "Quality-of-Life Assessment" (11 trials), "Pembrolizumab" (10 trials), "Biospecimen Collection" (9 trials) and "Nivolumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "CTCA at Western Regional Medical Center" are 46 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CTCA at Western Regional Medical Center". undefined are not yet recruiting, 15 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in CTCA at Western Regional Medical Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in CTCA at Western Regional Medical Center, 9 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".